University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic resistance more broadly.
FDA open to use of new MRD endpoint ahead of advisory committee meeting
The FDA seems open to a new endpoint that could accelerate the development of new treatments for multiple myeloma. The agency’s Oncologic Drugs Advisory Committee
April 11, 2024